CTI BioPharma To Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update on Monday, March 6, 2023PRNewsWire • 02/23/23
CTI BioPharma: Limited Cash Runway, But Better Than Expected Commercial LaunchSeeking Alpha • 01/20/23
Has CTI BioPharma (CTIC) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 12/28/22
CTI BioPharma Presents New Anemia Benefit Data from Pacritinib Program at the 2022 American Society of Hematology (ASH) Annual Meeting and ExpositionPRNewsWire • 12/11/22
CTI BioPharma Announces Oral Presentation at the 2022 American Society of Hematology (ASH) Annual Meeting and ExpositionPRNewsWire • 11/03/22
CTI BioPharma to Report Third Quarter 2022 Financial Results on November 7, 2022PRNewsWire • 10/27/22
CTI BioPharma Announces Presentation of New Anemia Benefit Data from Pacritinib Program at the Society of Hematologic Oncology (SOHO) Tenth Annual MeetingPRNewsWire • 09/21/22
CTI BioPharma Corp. (CTIC) CEO Adam Craig on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/09/22